Therefore, the developmentof inhibitors targeting MerTK while avoiding inhibition of Tyro3 holdspromise to suppress tumor growth and alleviate immunosuppression withinthe tumor microenvironment, without inducing neurotoxicity. Here, MERTK is linked to neoplasm.